Professor of Medicine, Stanford University

Internal Medicine

Dr. Shelley R. Salpeter is an expert in the field of Internal Medicine. He studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine He received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Shelley R. Salpeter is also published. He has 25 publications published. The lastest publication: "The Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in the Hospital Setting: A Preliminary Report.' He is registered with Medicare and accepts Medicare payments.

Publications

---

• The Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in the Hospital Setting: A Preliminary Report.
• Very-Low-Dose Methadone: Authors' Response.
• The Use of Very-Low-Dose Methadone for Palliative Pain Control and the Prevention of Opioid Hyperalgesia.
• Systematic Review of Cancer Presentations with a Median Survival of Six Months or Less.
• Systematic Review of Noncancer Presentations with a Median Survival of 6 Months or Less.
• Effect of KRAS Mutational Status in Advanced Colorectal Cancer on the Outcomes of Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: A Systematic Revie...
• Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.
• Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women.
• Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis.
• The cost-effectiveness of hormone therapy in younger and older postmenopausal women.
• Systematic review: the effects of growth hormone on athletic performance.
• Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.
• Letter by Kielstein et al regarding article, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowe...
• Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.
• Systematic review of clinical outcomes in Chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.
• Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.
• Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
• Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.
• Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis.
• Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.
• Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.
• Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
• Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

Schools

---

• University Of California San Francisco School Of Medicine

• New England Medical Center

• Brigham and Women39s Hospital

• Cornell University

Conditions Treated

---

• Age-Related Cognitive Decline
• Chronic Diseases
• Frailty

Doctors Specialties

---

• Geriatric Medicine
• Internal Medicine

Accepted Insurances

---

• Medicare MCR

Awards

---

• Regional Top Doctor
• CMS Meaningful Use Stage 1 Certification

Education

---

• Brigham and Women's Hospital
• Tufts Medical Center
• University of California San Francisco School of Medicine

Hospital

---

• Mills-Peninsula Health Services

Drug Facts

---

NPI NUMBER		1770688848
NPPES Provider LastName		SALPETER
NPPES Provider FirstName		SHELLEY
NPPES Provider ZIPCode		944012824
NPPES Provider State		CA
Specialty Description		Geriatric Medicine
Total Claim Count		947.0
Distinct Opioid Count		2.0
Opioid Claim Count		53.0
Percent Opioid Claims		5.6

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1770688848
Last Name Of The Provider	SALPETER
First Name Of The Provider	SHELLEY
View All

Similar Doctors

---

	Dr. Susan Joseph, MD This Doctor is OpenDoctor Recommended.
	Dr. Diana V. Jao, MD This Doctor is OpenDoctor Recommended.
	Dr. Donald B. Jaffe, MD This Doctor is OpenDoctor Recommended.
	Dr. Christina M. Rincon, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph Broderick, MD This Doctor is OpenDoctor Recommended.
	Dr. Anne F. Benton, MD
	Dr. Monique S. Vance, MD
	Dr. Dean G. Kardassakis, MD This Doctor is OpenDoctor Recommended.
	Dr. Rebecca Ashe, MD
	Dr. Robert Gross, DO
	Dr. Nancy Inforzato, MD This Doctor is OpenDoctor Recommended.
	Dr. Diane E. Oliver, MD
	Dr. Ian Y. Lin, MD
	Dr. Swati Awsare, MD This Doctor is OpenDoctor Recommended.
	Dr. Victoria N. Ramirez, MD
	Derek L. Bigler

---

Doctor Directory | TOS | twitter | FB | Angel | blog